Literature DB >> 28679590

Unique sex- and age-dependent effects in protective pathways in acute kidney injury.

Ravindra Boddu1, Chunlan Fan1, Sunil Rangarajan1, Bhuvana Sunil1, Subhashini Bolisetty1, Lisa M Curtis2,3.   

Abstract

Sex and age influence susceptibility to acute kidney injury (AKI), with young females exhibiting lowest incidence. In these studies, we investigated mechanisms which may underlie the sex/age-based dissimilarities. Cisplatin (Cp)-induced AKI resulted in morphological evidence of injury in all groups. A minimal rise in plasma creatinine (PCr) was seen in Young Females, whereas in Aged Females, PCr rose precipitously. Relative to Young Males, Aged Males showed significantly, but temporally, comparably elevated PCr. Notably, Aged Females showed significantly greater mortality, whereas Young Females exhibited none. Tissue KIM-1 and plasma NGAL were significantly lower in Young Females than all others. IGFBP7 levels were modestly increased in both Young groups. IGFBP7 levels in Aged Females were significantly elevated at baseline relative to Aged Males, and increased linearly through day 3, when these levels were comparable in both Aged groups. Plasma cytokine levels similarly showed a pattern of protective effects preferentially in Young Females. Expression of the drug transporter MATE2 did not explain the sex/age distinctions. Heme oxygenase-1 (HO-1) levels (~28-kDa species) showed elevation at day 1 in all groups with highest levels seen in Young Males. Exclusively in Young Females, these levels returned to baseline on day 3, suggestive of a more efficient recovery. In aggregate, we demonstrate, for the first time, a distinctive pattern of response to AKI in Young Females relative to males which appears to be significantly altered in aging. These distinctions may offer novel targets to exploit therapeutically in both females and males in the treatment of AKI.

Entities:  

Keywords:  Cisplatin; acute kidney injury; aging; autophagy; cytokines; female; heme oxygenase-1; kidney injury markers; sex differences

Mesh:

Substances:

Year:  2017        PMID: 28679590      PMCID: PMC5625098          DOI: 10.1152/ajprenal.00049.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  111 in total

1.  Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury.

Authors:  Ravindra Boddu; Travis D Hull; Subhashini Bolisetty; Xianzhen Hu; Mark S Moehle; João Paulo Lima Daher; Ahmed Ibrahim Kamal; Reny Joseph; James F George; Anupam Agarwal; Lisa M Curtis; Andrew B West
Journal:  Hum Mol Genet       Date:  2015-04-22       Impact factor: 6.150

Review 2.  Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

Authors:  D Lebwohl; R Canetta
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

3.  Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group.

Authors:  G M Chertow; J M Lazarus; E P Paganini; R L Allgren; R A Lafayette; M H Sayegh
Journal:  J Am Soc Nephrol       Date:  1998-04       Impact factor: 10.121

4.  Acute kidney injury in older adults.

Authors:  Sharon Anderson; Basil Eldadah; Jeffrey B Halter; William R Hazzard; Jonathan Himmelfarb; Frances McFarland Horne; Paul L Kimmel; Bruce A Molitoris; Mahadev Murthy; Ann M O'Hare; Kenneth E Schmader; Kevin P High
Journal:  J Am Soc Nephrol       Date:  2011-01       Impact factor: 10.121

5.  Sex Differences and Renal Protection: Keeping in Touch with Your Feminine Side.

Authors:  Vesna D Garovic; Phyllis August
Journal:  J Am Soc Nephrol       Date:  2016-05-17       Impact factor: 10.121

Review 6.  Effects of aging on renal function and regenerative capacity.

Authors:  Emaad M Abdel-Rahman; Mark D Okusa
Journal:  Nephron Clin Pract       Date:  2014-09-24

7.  Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer.

Authors:  Takanori Miyoshi; Nobuhiro Misumi; Mikako Hiraike; Yuki Mihara; Takashi Nishino; Minako Tsuruta; Yosei Kawamata; Yoichi Hiraki; Aki Kozono; Masao Ichiki
Journal:  Biol Pharm Bull       Date:  2016       Impact factor: 2.233

8.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

9.  Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress.

Authors:  Qing S Lin; Sebastian Weis; Guang Yang; Tiangang Zhuang; Aida Abate; Phyllis A Dennery
Journal:  Free Radic Biol Med       Date:  2007-12-04       Impact factor: 7.376

10.  Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation.

Authors:  Jun-Te Hsu; Wen-Hong Kan; Chi-Hsun Hsieh; Mashkoor A Choudhry; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  J Leukoc Biol       Date:  2007-07-26       Impact factor: 4.962

View more
  25 in total

Review 1.  Evolution, kidney development, and chronic kidney disease.

Authors:  Robert L Chevalier
Journal:  Semin Cell Dev Biol       Date:  2018-06-05       Impact factor: 7.727

2.  Cutaneous exposure to lewisite causes acute kidney injury by invoking DNA damage and autophagic response.

Authors:  Ritesh K Srivastava; Amie M Traylor; Changzhao Li; Wenguang Feng; Lingling Guo; Veena B Antony; Trenton R Schoeb; Anupam Agarwal; Mohammad Athar
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-17

Review 3.  Sex differences in renal mitochondrial function: a hormone-gous opportunity for research.

Authors:  Regina F Sultanova; Ryan Schibalski; Irina A Yankelevich; Krisztian Stadler; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-11-02

4.  COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease.

Authors:  S Rangarajan; G Rezonzew; P Chumley; H Fatima; M Y Golovko; W Feng; P Hua; E A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-16

5.  Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.

Authors:  Kelly A Hyndman; Malgorzata Kasztan; Luciano D Mendoza; Sureena Monteiro-Pai
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

Review 6.  Sex differences in stroke: Challenges and opportunities.

Authors:  Cheryl D Bushnell; Seemant Chaturvedi; Kathy R Gage; Paco S Herson; Patricia D Hurn; Monik C Jiménez; Steven J Kittner; Tracy E Madsen; Louise D McCullough; Mollie McDermott; Mathew J Reeves; Tatjana Rundek
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-17       Impact factor: 6.200

7.  Heme oxygenase-2 protects against ischemic acute kidney injury: influence of age and sex.

Authors:  Karl A Nath; Vesna D Garovic; Joseph P Grande; Anthony J Croatt; Allan W Ackerman; Gianrico Farrugia; Zvonimir S Katusic; John D Belcher; Gregory M Vercellotti
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-19

8.  Divergent effects of AKI to CKD models on inflammation and fibrosis.

Authors:  L M Black; J M Lever; A M Traylor; B Chen; Z Yang; S K Esman; Y Jiang; G R Cutter; R Boddu; J F George; A Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-13

Review 9.  UAB-UCSD O'Brien Center for Acute Kidney Injury Research.

Authors:  Lisa M Curtis; James George; Volker Vallon; Stephen Barnes; Victor Darley-Usmar; Sucheta Vaingankar; Gary R Cutter; Orlando M Gutierrez; Michael Seifert; Joachim H Ix; Ravindra L Mehta; Paul W Sanders; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-03-29

10.  Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.

Authors:  Marije S Koks; Gurbey Ocak; Britt B M Suelmann; Cornelia A R Hulsbergen-Veelken; Saskia Haitjema; Marieke E Vianen; Marianne C Verhaar; Karin A H Kaasjager; Meriem Khairoun
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.